PLCL1 and esophageal cancer: Cui et al. found that miR-145 directly targeted the 3′UTR of phospholipase C epsilon (PLCE1) and then inhibited cell proliferation, migration and metastasis, as well as controlling the cytoskeleton dynamics of esophageal cancer [4].